Cohen Milstein Reminds Paragon 28, Inc. Investors of Nov. 29, 2024 Lead Plaintiff Deadline
Rhea-AI Summary
Cohen Milstein has announced a securities class action lawsuit against Paragon 28 (NYSE:FNA), a medical device company, regarding alleged false and misleading statements about financial statements and internal controls. The lawsuit covers investors who purchased shares between May 5, 2023, and September 20, 2024. Investors who suffered significant losses during this period have until November 29, 2024, to request appointment as lead plaintiff. The complaint, filed in the U.S. District Court for the District of Colorado, alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by current and former officers.
Positive
- None.
Negative
- Company faces securities class action lawsuit over alleged false financial statements
- Potential legal liabilities and associated costs from securities fraud allegations
- Questions raised about internal control effectiveness
Insights
WASHINGTON, DC / ACCESSWIRE / November 19, 2024 / Cohen Milstein reminds investors who lost money on securities of Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA) purchased between May 5, 2023 and September 20, 2024 that they can contact Cohen Milstein Sellers & Toll PLLC to learn about a pending securities class action lawsuit.
To learn about your legal options, click here to connect with a member of the Cohen Milstein team or contact Partner Molly J. Bowen at (202) 408-4600 or mbowen@cohenmilstein.com.
BACKGROUND: On October 18, 2024 a complaint against medical device company Paragon 28, Inc. was filed in the U.S. District Court for the District of Colorado. The complaint alleges that certain current and former officers made false and misleading statements to investors about financial statements and internal controls in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
NEXT STEPS: If you suffered a significant loss in Paragon 28 shares purchased during the proposed class period of May 5, 2023 to September 20, 2024, and are interested in serving as lead plaintiff in this action, you have until November 29, 2024 to request that the court appoint you as lead plaintiff. You are not required to file a lead plaintiff motion to share in any recovery in this action as a class member.
OUR FIRM: With more than 100 attorneys in eight offices, Cohen Milstein is one of the largest plaintiff-side law firms in the U.S., with more than four decades of experience litigating securities fraud cases. We have recovered billions of dollars to investors, including
Prior results do not guarantee a similar outcome. Attorney Advertising.
CONTACT INFORMATION:
Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Telephone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com
SOURCE: Cohen Milstein Sellers & Toll PLLC
View the original press release on accesswire.com